() news

Estee Lauder Cos. Cl A Stock Rises 4.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Estee Lauder Cos. Cl A rose 4.0% to $98.05 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,811.54 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. Estee Lauder Cos. Cl A closed 19.4% short of its 52-week high of $121.64, which the company reached on February 3rd. The stock outperformed some of its peers, as Johnson & Johnson rose 1.9% to $261.44, Procter & Gamble Co. rose 0.4% to $151.23, and Coty Inc. Cl A rose 2.15% to $2.85. Trading volume totaled 2.7 million, compared to the 50-day average of 3.2 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:35 ET (20:35 GMT)

Estée Lauder appoints Gaétane Baudry SVP, global general manager of Bobbi Brown

The Estée Lauder Companies appointed Gaétane Baudry senior vice president, global general manager of Bobbi Brown, effective Oct. 8, 2026. Baudry was most recently global brand president of Shu Uemura at L’Oréal Luxe. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Estée Lauder Companies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080800BIZWIRE_USPR_____20261008_BW525584) on October 08, 2026, and is solely responsible for the information contained therein.

BUZZ—US Stock Market Updates—Cenovus Energy, TeraWulf, Alector

Workspace search string for single stock price trends: STXBZ "Today’s Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Briefing": https://refini.tv/3dKUyB8 Reuters, October 5 - At Monday’s opening, major Wall Street indexes were flat, with tech stocks pulling back from record highs. As Treasury yields and oil prices remain elevated, investors are seeking new clues on the direction of monetary policy. Highlights: ** Cenovus Energy CVE.TO — Cenovus agreed to acquire Athabasca for 5.7 billions CAD; stock price dropped nL4N45R0RM ** Establishment Labs ESTA.O — Stock rose after FDA approved Motiva implants in additional sizes nL4N45R0SB ** Bristol Myers Squibb BMY.N — Leerink downgraded rating, citing pipeline risks nL4N45R0PN ** TeraWulf WULF.O — Doubled power capacity at Kentucky data center campus; shares up nL4N45R0QG ** Texas Roadhouse TXRH.O — Evercore ISI upgraded to “outperform”; stock rose nL6N45R0P2 ** Lumexa Imaging LMRI.O — Truist initiated coverage with “buy” rating; shares up nL6N45R0NS ** Alector ALEC.O — Stock surged after agreement with Genentech on experimental Parkinson’s drug nL6N45R0NF ** Align Technology ALGN.O — Broker downgraded to “neutral” amid slowing demand; stock declined nL4N45R0NV ** Insmed INSM.O — Shares fell after CFO Sara Bonstein resigned nL4N45R0O4 ** RXO RXO.N — C.H. Robinson announced $5.8 billions acquisition plan; RXO shares up nL6N45R0N4 ** Harley-Davidson HOG.N — Citi upgraded to “buy”; shares rose nL6N45R0M3 ** GEO Group GEO.N — Stock climbed after $950 millions ICE facility sale and expanded buyback nL6N45R0MR ** Vistra VST.N — Reportedly to receive $4.2 billions US nuclear loan; shares up nL4N45R0L8 ** Vaxcyte PCVX.O — Stock surged after successful late-stage clinical results for pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N — Barclays upgraded to “overweight”; shares up nL6N45R0HX ** PTC PTC.O — Schneider Electric agreed to acquire PTC for $22.6 billions; stock surged nL6N45R0HV ** Petrobras PBR.N, Itaú Unibanco ITUB.N, MercadoLibre BBD.N, Nu Holdings NU.N — Strong performance by Bolsonaro lifted market sentiment, Brazilian ADR shares soared. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. As automated translation may contain errors or miss required context, Reuters does not guarantee the accuracy of the automated translation, which is provided solely for reader convenience. Reuters accepts no liability for any damage or loss caused by use of the automated translation function.)

BUZZ - US Stock Market Dynamics - RXO, Harley-Davidson, Vistra

Search string for querying individual stock trends in the workspace: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Brief" newsletter: https://refini.tv/3dKUyB8 Reuters, October 5 - On Monday, U.S. stock index futures edged lower as tech stocks retreated after reaching record highs. As Treasury yields and oil prices remain elevated, investors are seeking new clues about the direction of monetary policy. .N ** RXO RXO.N: Market focus — RXO shares rose following C.H. Robinson's announcement of a 5.8 billions USD acquisition plan nL6N45R0N4 ** Harley-Davidson HOG.N: Market focus — Citi upgraded Harley-Davidson to "Buy," shares climbed nL6N45R0M3 ** GEO Group GEO.N: Spotlight — GEO gained as it sold ICE facilities for 950 millions USD and expanded its stock buyback nL6N45R0MR ** Vistra VST.N: Spotlight — Vistra rallied as it was reportedly set to receive a 4.2 billions USD U.S. nuclear loan nL4N45R0L8 ** Vaxcyte PCVX.O: Spotlight — Vaxcyte surged after positive late-stage clinical trial data for its pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N: Spotlight — Barclays upgraded Estée Lauder to "Overweight," shares advanced nL6N45R0HX ** PTC PTC.O: Spotlight — Schneider Electric agreed to acquire PTC for 22.6 billions USD, shares jumped nL6N45R0HV (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automatic translation may contain errors or fail to convey the required context, Reuters does not guarantee the accuracy of automatically translated texts and provides them solely for readers’ convenience. Reuters accepts no liability for any damages or losses arising from the use of automated translation features.)

BUZZ—US Stock Market Trends: Estée Lauder, PTC, Vaxcyte

Search string for checking individual stock movements in the workspace: STXBZ "Today's Outlook" bulletin: https://refini.tv/3LI4BU7 "Morning News Brief": https://refini.tv/3dKUyB8 Reuters, October 5 - On Monday, U.S. stock index futures edged lower as technology stocks pulled back after reaching historic highs. With Treasury yields and oil prices still elevated, investors are seeking new clues about the direction of monetary policy. .N ** Vaxcyte PCVX.O: Market spotlight—Vaxcyte's stock surged after successful late-stage clinical trials for its pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N: Highlight—Barclays has upgraded Estée Lauder to "overweight," sending the stock higher nL6N45R0HX ** PTC PTC.O: Market news—Schneider Electric agreed to acquire PTC for $22.6 billions, driving the stock up nL6N45R0HV (Note: For convenience, Reuters provides automated translations of its reports into several other languages for non-English speakers. Automated translations may contain errors or lack necessary context, so Reuters does not guarantee their accuracy. They are provided solely for readers' convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation tools.)

Wells Fargo Adjusts PT on Estee Lauder to $95 From $104, Keeps Equalweight Rating

06:40 AM EDT, 10/05/2026 (MT Newswires) -- Estee Lauder Companies (EL) has an average rating of overweight and mean price target of $108.98, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Goldman Sachs Adjusts Price Target on Estee Lauder to $116 From $112, Keeps Buy Rating

06:40 AM EDT, 10/05/2026 (MT Newswires) -- Estee Lauder Companies (EL) has an average rating of overweight and mean price target of $108.98, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

THE ESTEE LAUDER COMPANIES INC. <EL.N>: WELLS FARGO CUTS TARGET PRICE TO $95 FROM $104

THE ESTEE LAUDER COMPANIES INC. : WELLS FARGO CUTS TARGET PRICE TO $95 FROM $104

BUZZ - Barclays upgrades Estée Lauder rating to "Overweight", stock price rises

October 5th - The stock price of cosmetics manufacturer Estée Lauder (EL.N) rose 2.2% in pre-market trading to $93.98. Barclays upgraded the stock rating from "Neutral" to "Overweight" and raised the target price from $97 to $108. The bank stated that the company’s expected sales growth and profitability in the coming years make it one of the most attractive companies in the Global Consumer Staples Index. It was noted that, since announcing its transformation plan, the company (link) has achieved more balanced revenue growth over the past seven quarters, contrary to previous market expectations that reshaping its operating model would require significant time and investment. Growth has been recorded in all regions, and strong North America growth is expected to continue this quarter; structural changes to the operating model are expected to support continued reinvestment and gradually drive the EBIT margin up to double-digit percentage highs. The average rating given by 44 brokerages is "Buy," with a median target price of $129—data compiled by London Stock Exchange Group (LSEG). As of the last trading day’s close, the stock had declined about 12% year-to-date. (For the convenience of non-English speakers, Reuters has automated the translation of its reports into several other languages. Since automated translation may be inaccurate or fail to capture the intended context, Reuters makes no representations as to the accuracy of these translations and provides them solely for reader convenience. Reuters is not responsible for any damage or losses arising from the use of automated translations.)

THE ESTÉE LAUDER COMPANIES <EL.N>: BARCLAYS RAISES TARGET PRICE TO $108 FROM $97

THE ESTÉE LAUDER COMPANIES : BARCLAYS RAISES TARGET PRICE TO $108 FROM $97

Estee Lauder Cos. Cl A Stock Rises 4.1%, Outperforms Peers

Elf Beauty's Rhode Expansion in Sephora Europe Likely to Offer Sale Tailwinds, BofA Says

Estee Lauder Forms Global Partnership With Profound on AI Brand Discovery

86% of S&P 500 Components Beat Earnings Expectations! AI Boom Fuels S&P 500 Profit Growth, Full-Year Growth Forecast Raised to 32%

The full-year profit expectations for the S&P 500 Index are rising, supported by the artificial intelligence boom and stronger-than-expected earnings performance in the first half of the year.

Estee Lauder Broadens Transformation and Digital Leadership Roles

Layoffs Reach Lowest August Tally Since 2022, Challenger Report Shows

Goldman Sachs September "Conviction List" Update: US stocks include Vertex Pharmaceuticals (VRTX.US); top picks for European stocks are Rhein, Adyen, and Talanx

Goldman Sachs has updated its "Conviction List" for the US and European markets.

UBS Adjusts Price Target on Elastic to $105 From $85, Maintains Buy Rating

Bath & Body Works Upgrades Earnings Outlook Following Second-Quarter Beat; Shares Rise

Ulta Beauty Second-Quarter Same-Store Sales Poised for Beat, Deutsche Bank Says

Estee Lauder Cos. Cl A Stock Rallies 6.0%, Outperforms Peers

Top RWA Projects by Social Activity